EP
QDEL icon

Eversept Partners’s QuidelOrtho QDEL Stock Holding History

Eversept Partners’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,132
Closed -$529K – 104
2021
Q1 		$529K Sell
4,132
-36,451
-90% -$6.73M 0.03% 83
2020
Q4 		$7.29M Buy
40,583
+31,240
+334% +$6.94M 0.86% 31
2020
Q3 		$2.05M Buy
+9,343
New +$2.08M 0.46% 37

Other funds holding QDEL

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.97B AUM 15.72% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Eversept Partners's QDEL Position: Q2 2021 in Review

Eversept Partners sold out of QuidelOrtho (QDEL) in Q2 2021, closing a stake of 4,132 shares — an estimated $529K sold.

Eversept Partners first reported a position in QDEL in Q3 2020 and held it in 3 quarters. The position peaked at $7.29M in Q4 2020. 331 funds tracked by Wall St. Rank hold QDEL as of Q2 2021.

  • Eversept Partners reported no remaining QuidelOrtho position as of Q2 2021 after selling out during the quarter.
  • Eversept Partners sold 4,132 QuidelOrtho shares in Q2 2021, an estimated $529K.
  • Eversept Partners first reported a position in QuidelOrtho in Q3 2020 and held it in 3 quarters.
  • Eversept Partners's QuidelOrtho position peaked at $7.29M in Q4 2020.
  • 331 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2021.

Based on Eversept Partners's 13F filing for Q2 2021, filed 16 Aug 2021.